Showing results (21-30 of 180) with videos related to
Sort By:
Pageof 18
Experimental Neurology|April 16, 2014
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosisMichel Varrin-Doyer, Scott S Zamvil, Ulf Schulze-TopphoffJournal of Neuroscience Methods|September 2, 2003
Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosisJulie K Olson, Scott S Zamvil, Stephen D MillerCurrent Opinion in Immunology|October 11, 2011
B cells in multiple sclerosis: connecting the dotsH-Christian von Büdingen, Amit Bar-Or, Scott S ZamvilTrends in Immunology|March 15, 2006
A neuropeptide in immune-mediated inflammation, Y?Thomas Prod'homme, Martin S Weber, Lawrence Steinman, et al.Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: using statins to treat neuroinflammatory diseaseMartin S Weber, Thomas Prod'homme, Lawrence Steinman, et al.The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.CNS Drugs|September 28, 2005
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstaclesOliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.Neurology|December 15, 2004
Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosisTimothy K Vartanian, Scott S Zamvil, Edward Fox, et al.Neurobiology of Disease|May 8, 2012
K+ channel alterations in the progression of experimental autoimmune encephalomyelitisPeter I Jukkola, Amy E Lovett-Racke, Scott S Zamvil, et al.Current Opinion in Neurology|May 15, 2007
Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practiceFiona Costello, Olaf Stüve, Martin S Weber, et al.Pageof 18